Chi Sheng Pharma & Biotech Co., Ltd. (4111)
Market Closed
16 Oct, 05:30 AM
TWSE TWSE Primary NT$
28. 75
+0.1
+0.349%
NT$
1.73B Market Cap
- P/E Ratio
4% Div Yield
31,790 Volume
- Eps
NT$ 28.65
Previous Close Want to track 4111 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Chi Sheng Pharma & Biotech Co., Ltd. (4111) Statistics
Valuation metrics
Market Cap 1.73B
Enterprise value 1.31B
Trailing P/E (ttm) 9.21
Forward P/E -
PEG ratio 0.33
Price/Sales (ttm) 1.22
Price/Book (mrq) 1.24
Enterprise Value/Revenue 0.92
Enterprise Value/EBITDA 4.55
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 45.53K
Average volume (90 days) 66.22K
Price summary
52-Week low 28.4
52-Week high 30.95
Beta -
50-Day moving average 28.89
200-Day moving average 29.61
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate 1.3
Trailing annual dividend yield 0.0448%
5-Year annual dividend yield -
Payout ratio 0.3
Dividend Date 22 Sep 2026
Ex-Dividend Date 25 Aug 2026
Last split factor 21:20
Last split Date 26 Aug 2025
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin 0.13%
Operating margin 0.14%
Operational effectiveness
Return on assets 0.09%
Return on equity 0.14%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 23.75
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) 3.16
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 7.89
Total debt (mrq) -
Total Debt/Equity (mrq) 0.03
Current ratio (mrq) 1.8%
Book value per share (mrq) 23.42
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
2026 © Marketlog. All Rights Reserved.
